-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E4oXeY/beDJkYkhuLyLs7nq/0t4eav/a2Lb4qyao/YCiJ0HG4jZICfyCjyAS30wR /2yeCjyyeTFHYp3dvFxTGw== 0001209191-05-006605.txt : 20050203 0001209191-05-006605.hdr.sgml : 20050203 20050203152728 ACCESSION NUMBER: 0001209191-05-006605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050201 FILED AS OF DATE: 20050203 DATE AS OF CHANGE: 20050203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOVENBERG WALTER M PHD CENTRAL INDEX KEY: 0001213100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 05573142 MAIL ADDRESS: STREET 1: 3008 BURNING FREE LN CITY: CINCINNATI STATE: OH ZIP: 45237 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1204 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-02-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001213100 LOVENBERG WALTER M PHD C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 1 0 0 0 Common Stock 2005-02-01 4 M 0 1667 9.25 A 9719 D Common Stock 2005-02-01 4 S 0 223 65.00 D 9496 D Common Stock 2005-02-01 4 S 0 447 65.10 D 9049 D Common Stock 2005-02-01 4 S 0 223 65.15 D 8826 D Common Stock 2005-02-01 4 S 0 774 65.16 D 8052 D Stock Option (Right to Buy) 9.25 2005-02-01 4 M 0 1667 0.00 D 1997-03-25 2006-03-24 Common Stock 1667 11665 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2005-02-03 -----END PRIVACY-ENHANCED MESSAGE-----